To conclude, Metformin adjunct therapy in Asian Indian adolescents with T1D demonstrated a favourable effect on glycemic control, glycemic variability, insulin sensitivity, lipid profile, vascular function, body mass index and body fat composition with a good safety profile when administered for 9 months. The gene discussed is INS; the disease is type 1 diabetes mellitus.